Boostrix Polio

Boostrix Polio Description

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
1 dose (0.5 mL) contains: Diphtheria toxoid1 not less than 2 International Units (IU) (2.5 Lf), Tetanus toxoid1 not less than 20 International Units (IU) (5 Lf), Bordetella pertussis antigens: Pertussis toxoid1 8 micrograms, Filamentous haemagglutinin1 8 micrograms, Pertactin1 2.5 micrograms), Inactivated poliovirus: type 1 (Mahoney strain)2 40 D-antigen unit, type 2 (MEF-1 strain)2 8 D-antigen unit, type 3 (Saukett strain)2 32 D-antigen unit.
1adsorbed on aluminium hydroxide, hydrated (Al(OH)3) 0.3 milligrams Al3+ and aluminium phosphate (AlPO4) 0.2 milligrams Al3+.
2propagated in VERO cells.
Boostrix Polio is a turbid white suspension. Upon storage, a white deposit and clear supernatant can be observed. This is a normal finding.
Excipients/Inactive Ingredients: Medium 199 (as stabilizer), sodium chloride, water for injections.
Neomycin sulfate and polymyxin B sulfate are present as residues from the manufacturing process.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in